Edgar Filing: TUMOLO ANNETTE

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â TUMOLO ANNETTE

2. Date of Event Requiring Statement (Month/Day/Year)
09/18/2017

3. Issuer Name and Ticker or Trading Symbol
BIO RAD LABORATORIES INC [BIO, BIOB]

(Last)

(First)

(Middle)

C/O BIO-RAD LABORATORIES, INC.,Â 1000 ALFRED NOBEL DRIVE

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Executive Vice President

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

HERCULES,Â CAÂ 94547

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Bio-Rad A Common Stock	871.381	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	Â ⁽¹⁾	Â ⁽¹⁾	Bio-Rad A Common Stock	400	$ 0 ⁽⁶⁾	D	Â
Restricted Stock Units	Â ⁽²⁾	Â ⁽²⁾	Bio-Rad A Common Stock	800	$ 0 ⁽⁶⁾	D	Â
Restricted Stock Units	Â ⁽³⁾	Â ⁽³⁾	Bio-Rad A Common Stock	1,800	$ 0 ⁽⁶⁾	D	Â
Restricted Stock Units	Â ⁽⁴⁾	Â ⁽⁴⁾	Bio-Rad A Common Stock	2,400	$ 0 ⁽⁶⁾	D	Â
Restricted Stock Units	Â ⁽⁵⁾	Â ⁽⁵⁾	Bio-Rad A Common Stock	3,000	$ 0 ⁽⁶⁾	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁷⁾	09/07/2026	Bio-Rad A Common Stock	3,000	$ 159.32	D	Â
Non-Qualified Stock Option (right to buy)	Â ⁽⁸⁾	09/05/2027	Bio-Rad A Common Stock	3,000	$ 215.98	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
TUMOLO ANNETTE C/O BIO-RAD LABORATORIES, INC. 1000 ALFRED NOBEL DRIVE HERCULES,Â CAÂ 94547	Â	Â	Â Executive Vice President	Â

Signatures

Annette Tumolo		09/26/2017
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The restricted stock units vest in five equal annual installments beginning September 11, 2014.
(2)	The restricted stock units vest in five equal annual installments beginning September 10, 2015.
(3)	The restricted stock units vest in five equal annual installments beginning September 11, 2016.
(4)	The restricted stock units vest in five equal annual installments beginning September 7, 2017.
(5)	The restricted stock units vest in five equal annual installments beginning September 5, 2018.
(6)	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
(7)	The options vest in five equal annual installments beginning September 7, 2017.
(8)	The options vest in five equal annual installments beginning September 5, 2018.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.